Gsk Plc ADR (GSK)
$39.39
0.04 (0.10%)
GSK Stock Quote Delayed 30 Minutes
Bank on Gilead Sciences, Inc. (GILD) Stock Getting Its Mojo Back
I don't know if Gilead (GILD) actually flipped from being a falling machete to shooting star, but I'm willing to bank on GILD stock.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
212.12B
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
2.79M
Day's Range
$39.30 - $39.58
52-Week Range
$33.67 - $45.92
Dividend & Yield
$1.44 (3.67%)
GSK Stock Predictions, Articles, and Gsk Plc ADR News
16 Pharmaceuticals Stocks to Sell Now
The overall ratings of 16 Pharmaceuticals stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
13 Pharmaceuticals Stocks to Sell Now
The ratings of 13 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
GlaxoSmithKline plc (ADR) (GSK) Seeks FDA Approval for New Shingles Vaccine
GlaxoSmithKline (GSK), a healthcare company, is seeking approval from the U.S. Food and Drug Administration for a shingles vaccine.
11 Pharmaceuticals Stocks to Buy Now
The grades of 11 Pharmaceuticals stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
4 Pharmaceuticals Stocks to Buy Now
The grades of 4 Pharmaceuticals stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
Gilead Sciences, Inc. (GILD) Investors Are Drowning in Negativity
Gilead Sciences (GILD) stock takes yet another hit as a rival comes after Gilead Sciences' lucrative HIV treatment market.
GSK, GOOGL: GlaxoSmithKline plc (ADR), Alphabet Inc Team Up on Bioelectronics
GlaxoSmithKline (GSK) is teaming up with Alphabet's (GOOG,GOOGL) Verily Life Sciences to form a new company called 'Galvani Bioelectronics.'
7 Pharmaceuticals Stocks to Buy Now
This week, 7 Pharmaceuticals stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
This Week’s 43 Biggest Stock Upgrades and Downgrades
It pays to stay on top of the latest profit opportunities. Today's post is a great place to start with these updated Portfolio Grader ratings
5 Pharmaceuticals Stocks to Buy Now
The grades of 5 Pharmaceuticals stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
Prepare for Earnings Season with These 49 Trades
It pays to stay on top of the latest profit opportunities. Today's blog post is a great place to start with these 49 trades to consider
Big Trouble for U.S. Stocks in China
Doing business in China can be hazardous to the health of U.S. stocks. Here's a look at just a few of the challenges and risks.
